ULTRALIFE CORP Research And Development Expense

• ULTRALIFE CORP showed an increase of +25.8% in Research And Development Expense from 2024 to 2025.
• This data is from ULTRALIFE CORP's annual report (Form 10-K), filed with the SEC on March 23, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), ULTRALIFE CORP's Research And Development Expense has grown by 10.0%.
• Historical annual values: Fiscal year 2025: $10.40 million | Fiscal year 2024: $8.27 million | Fiscal year 2023: $7.53 million | Fiscal year 2022: $7.08 million | Fiscal year 2021: $6.83 million | Fiscal year 2020: $5.95 million | Fiscal year 2019: $6.81 million | Fiscal year 2018: $4.51 million | Fiscal year 2017: $4.74 million | Fiscal year 2016: $5.95 million | Fiscal year 2015: $5.60 million | Fiscal year 2014: $5.33 million | Fiscal year 2013: $5.86 million | Fiscal year 2012: $7.22 million | Fiscal year 2011: $8.59 million | Fiscal year 2010: $8.76 million | Fiscal year 2009: $9.45 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026